Context

Proteor has orchestrated a secondary Owner Buy-Out (OBO Bis). The transaction allows Ardian Growth to exit its minority position, which it held since the primary OBO in 2021, realizing a return of approximately 3x money. The founding Archambeaud family remains the majority shareholder, continuing its 4th-generation leadership. The strategic rationale for this new round is to consolidate Proteor’s industrial activity and fund future international acquisitions, building on the successful integration of Freedom Innovations in the USA. The deal was supported by a diverse pool of national and regional banks providing senior debt. This partnership aims to strengthen Proteor’s position as a global integrated player, balancing its manufacturing expertise with its extensive network of orthopedic centers amidst a consolidating global market.

Target

Founded in 1913, PROTEOR is a world-class leader in the orthotics and prosthetics (O&P) market. The group specializes in high-tech orthopedic components (microprocessor knees, bionic feet) and custom-made medical devices. It operates a dual model combining manufacturing (R&D/Sales) and a large network of specialized care centers in France.